Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 1, 2008, Pages 55-60

  Mouala, Christian ^a,b   Houzé, Sandrine ^c   Guiguet, Marguerite ^a,b   Abboud, Philippe ^d   Pialoux, Gilles ^e   Viget, Nathalie ^f   Costagliola, Dominique ^a,b,g   Matheron, Sophie ^c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c BICHAT HOSPITAL   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f CENTRE HOSPITALIER DE TOURCOING   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CD4 cell count; HIV infection; Imported malaria; Severe falciparum malaria; Viral load; World Health Organization criteria

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; HALOFANTRINE; MEFLOQUINE; QUININE; VIRUS RNA;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; CHEMOSENSITIVITY; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE MALARIA; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS LOAD; WORLD HEALTH ORGANIZATION; DISEASE TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR; TRAVEL;

ADULT; AFRICA, NORTHERN; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; TRAVEL; VIRAL LOAD;

EID: 52049102084     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31817e635b     Document Type: Article

References (51)

1. Joint United Nations Programme on HIV/AIDS. AIDS Epidemic Update. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/ EpiUpdArchive/2007/default.asp. Accessed March 15, 2008.
2. World Health Organization Roll Back Malaria Partnership. World Malaria Report 2005. Available at: http://rbm.who.int/wmr2005/. Accessed March 24, 2008.
3. Snow RW, Guerra CA, Noor AM, et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214-217.
4. Muentener P, Schlagenhauf P, Steffen R. Imported malaria (1985-95): trends and perspectives. Bull World Health Organ. 1999;77:560-566.
5. Jelinek T, Schulte C, Behrens R, et al. Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis. 2002;34: 572-576.
6. World Health Organization Regional Office for Europe. Centralized Information System for Infectious Diseases (CISID)/Malaria 2006. Available at: http://data.euro.who.int/cisid/. Accessed March 24, 2008.
7. Goyet F, Legros F, Belkaid M, et al. Note on imported malaria in metropolitan France from 1993 to 1995. Bull Soc Pathol Exot. 1997;90: 257-259.
8. Danis M, Legros F, Thellier M, et al. Current data on malaria in metropolitan France. Med Trop (Mars). 2002;62:214-218.
9. Bruneel F, Hocqueloux L, Alberti C, et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am JRespir Crit Care Med. 2003;167:684-689.
10. World Health Organization, Communicable Diseases Cluster. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg. 1990;84(Suppl 2):1-65.
11. World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94(Suppl 1):S1-S90.
12. World Health Organization, Communicable Diseases Cluster. Erratum. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94:3.
13. Hoffman IF, Jere CS, Taylor TE, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS. 1999;13:487-494.
14. Chirenda J, Siziya S, Tshimanga M. Association of HIV infection with the development of severe and complicated malaria cases at a rural hospital in Zimbabwe. Cent Afr J Med. 2000;46:5-9.
15. Grimwade K, French N, Mbatha DD, et al. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS. 2004;18:547-554.
16. ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg. 2004;71(Suppl 2):41-54.
17. Whitworth JA, Hewitt KA. Effect of malaria on HIV-1 progression and transmission. Lancet. 2005;365:196-197.
18. Hewitt K, Steketee R, Mwapasa V, et al. Interactions between HIV and malaria in non-pregnant adults: evidence and implications. AIDS. 2006; 20:1993-2004.
19. Brentlinger PE, Behrens CB, Kublin JG. Challenges in the prevention, diagnosis, and treatment of malaria in human immunodeficiency virus infected adults in sub-Saharan Africa. Arch Intern Med. 2007;167:1827-1836.
20. Grabar S, Pradier C, Le Corfec E, et al. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS. 2000;14:141-149.
21. Organisation Mondiale de la Santé. Manuel de la Classification Statistique Internationale des Maladies, Traumatismes et Causes de Décès, revision 1975. Orginasation Mondiale de la Santé, Geneva; 1977.
22. Organisation Mondiale de la Santé. Classification Statistique Internationale des Maladies et des Problèmes de Santé Connexes. 10th révision. Available at: http://www.who.int/ classifications/icd/en/. Accessed March 16, 2008. Orginasation Mondiale de la Santé, Geneva; 1993.
23. Froude JR, Weiss LM, Tanowitz HB, et al. Imported malaria in the Bronx: review of 51 cases recorded from 1986 to 1991. Clin Infect Dis. 1992;15: 774-780.
24. Kain KC, Shanks GD, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis. 2001;33:226-234.
25. Institut de Veille Sanitaire. Actualisation des recommandations sanitaires pour les voyageurs 1996. Available at: http://www.invs.sante.fr/beh/ 1996/9623/beh-23-1996.pdf Accessed March 13, 2008.
26. Institut de Veille Sanitaire. Recommandations sanitaires pour les voyageurs 1997. Available at: http://www.invs.sante.fr/beh/1997/9726/beh-26- 1997.pdf Accessed March 12, 2008.
27. Institut de Veille Sanitaire. Recommandations sanitaires pour les voyageurs 1998. Available at: http://www.invs.sante.fr/beh/1998/9821/beh-21- 1998.pdf Accessed March 12, 2008.
28. Institut de Veille Sanitaire. Recommandations sanitaires pour les voyageurs 1999. Available at: http://wwwinvs.sante.fr/beh/1999/9923/beh-23-1999. pdf Accessed March 12, 2008.
29. Institut de Veille Sanitaire. Recommandations sanitaires pour les voyageurs 2000. Available at: http://www.invs.sante.fr/beh/2000/0025/beh-25- 2000.pdf Accessed March 12, 2008.
30. Institut de Veille Sanitaire. Recommandations sanitaires pour les voyageurs 2001. Available at: http://www.invs.sante.fr/beh/2001/28/beh-28-2001. pdf Accessed March 12, 2008.
31. Institut de Veille Sanitaire. Recommandations sanitaires pour les voyageurs 2002. Available at: http://www.invs.sante.fr/beh/2002/24/beh-24-2002. pdf Accessed March 12, 2008.
32. Institut de Veille Sanitaire. Recommandations sanitaires pour les voyageurs 2003. Available at: http://www.invs.sante.fr/beh/2003/26-27/beh-26-27- 2003.pdf Accessed March 12, 2008.
33. Bruneel F, Gachot B, Wolff M, et al. Blackwater fever. Presse Med. 2002; 31:1329-1334.
34. Delfraissy JF Prise en charge thérapeutique des personnes infectées par le VIH. Recommandations du groupe d'experts. ed. Paris: Flammarion Medecine-Sciences ed; 2000.
35. Stich A, Zwicker M, Steffen T, et al. Old age as risk factor for complications of malaria in non-immune travellers. Dtsch Med Wochenschr. 2003;128:309-314.
36. Schwartz E, Sadetzki S, Murad H, et al. Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. Clin Infect Dis. 2001;33:1774-1777.
37. Baird JK. Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol. 1998;92:367-390.
38. Legros F, Bouchaud O, Ancelle T, et al. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis. 2007;13:883-888.
39. Seeley J, Grellier R, Barnett T. Gender and HIV/AIDS impact mitigation in sub-Saharan Africa-recognising the constraints. SAHARA J. 2004; 1: 87-98.
40. Hetzel MW, Iteba N, Makemba A, et al. Understanding and improving access to prompt and effective malaria treatment and care in rural Tanzania: the ACCESS Programme. Malar J. 2007;6:83.
41. Cohen C, Karstaedt A, Frean J, et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis. 2005;41: 1631-1637.
42. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance. Mol Cell. 2000;4:861-871.
43. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344: 257-263.
44. Tinto H, Ouedraogo JB, Erhart A, et al. Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect Genet Evol. 2003;3:287-292.
45. Afrane YA, Zhou G, Lawson BW, et al. Effects of microclimatic changes caused by deforestation on the survivorship and reproductive fitness of Anopheles gambiae in western Kenya highlands. Am J Trop Med Hyg. 2006;74:772-778.
46. Hayward R, Saliba KJ, Kirk K. pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum. Mol Microbiol. 2005;55:1285-1295.
47. Walliker D, Hunt P, Babiker H. Fitness of drug-resistant malaria parasites. Acta Trop. 2005;94:251-259.
48. Meerman L, Ord R, Bousema J, et al. Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J Infect Dis. 2005;192:1651-1657.
49. Ranjit MR, Das A, Chhotray GP, et al. The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. Trop Med Int Health. 2004;9:857-861.
50. Kublin JG, Cortese JF, Njunju EM, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870-1875.
51. Giha HA, Elbashir MI, A-Elbasit AE, et al. Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Acta Trop. 2006;97:181-187.